nach oben

Erschienen in:

01.06.2019 | Case report

Finasteride

Acute localised exanthematous pustulosis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

» Editorial comment: Details of this case report have previously been published [see Reactions 1394 p22-23; 803068221], the authors stated that the patient received oral finasteride 1 mg/day [Propoecia] and was admitted with the symptoms of acute localised exanthematous pustulosis, which occurred after 2 months of finasteride initiation. …

Tresch S, et al. T cell-mediated acute localized exanthematous pustulosis caused by finasteride. Journal of Allergy and Clinical Immunology 129: 589-594, No. 2, Feb 2012. Available from: URL: https://doi.org/10.1016/j.jaci.2011.07.033 - Switzerland

Titel: Finasteride
Acute localised exanthematous pustulosis: case report
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-64009-4

Springer Medizin

Finasteride

Acute localised exanthematous pustulosis: case report

Excerpt

Weitere Artikel der Ausgabe 1/2019

Bcg

Ferric carboxymaltose

Dextromethorphan

Sodium valproate

Natalizumab

Octreotide

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Bcg

Ferric carboxymaltose

Dextromethorphan

Sodium valproate

Natalizumab

Octreotide